Keratinocyte growth factor improves alveolar barrier function: keeping claudins in line.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. The relative balance of GM-CSF and TGF-β1 regulates lung epithelial barrier function.American journal of physiology. Lung cellular and molecular physiology · 2015
   Article
2. Claudins: Gatekeepers of lung epithelial function.Seminars in cell & developmental biology · 2015
   Review
3. Roles for claudins in alveolar epithelial barrier function.Annals of the New York Academy of Sciences · 2012
   Article

Corrections and comments

• Comment on
  Keratinocyte growth factor enhances barrier function without altering claudin expression in primary alveolar epithelial cells.2010

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as